Senate Confirms Scott Gottlieb to Head FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailSenate Confirms Scott Gottlieb to head FDA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parabilis reports 72% response rate for desmoid tumor drug
- Cumberland Pharmaceuticals reports Phase 2a ifetroban trial results
- Lexicon's HCM trial enrolls 542 patients, exceeding 500 target
Create E-mail Alert Related Categories
FDA, PoliticsRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
